Canuk Seeds
420 Sponsor
Cannabinoid therapies have taken center stage when it comes to holistic health. There are hundreds of cannabinoids present in cannabis, most are non-psychoactive, and few have been heavily researched.
Cannabigerol (CBG) is present in many cannabis strains at low levels. We may be at the beginning of cannabinoid research. Here’s what we know about CBG so far.
This study is one of the few that look at CBG and how it interacts with our endocannabinoid system (ECS) and cannabinoid receptors.
Enzymes in the cannabis plant break CBGA down into these more prominent cannabinoids. That’s why most strains contain less than 1% CBG.
A few cannabis breeders are playing around with cross-breeding and genetics to produce higher CBG levels.
Your body has a built-in security system to promote homeostasis (body balance). We have cannabinoid receptors that act as messengers between our ECS and the rest of our body.
Cannabinoids from cannabis like CBG work with our ECS.
There are many reasons cannabinoids are beneficial. CBG is showing to be a vasodilator that has neuroprotective benefits. Meaning, cannabinoid therapies may be a valuable therapeutic treatment for symptoms associated with glaucoma.
Most studies are not human clinical trials. In an animal study, CBD effectively decreases inflammation related to IBS symptoms.
Like CBD and other non-psychoactive cannabinoids, CBG possesses antibacterial, antifungal, anti-inflammatory, and antitumor properties.
This study shows that CBG stays in the blood and can be a holistic treatment for unwanted symptoms brought on by stress.
The beginning of most of the cannabinoid’s journey starts with CBG. It could quite literally be the mother of cannabinoids.
This cannabinoid has an insane amount of potential. The therapeutic possibilities pique the interest of both consumers and researchers.
Some companies entering the cannabis scene focus specifically on CBD products. Minor cannabinoid research is gaining traction.
From alleviating physical pain to reducing stress and sadness, cannabinoids like CBG help your body heal itself- a scientific breakthrough.
You won’t see CBG on the market in masses any time soon.
There are so many hurdles a CBG cultivator has to overcome before he even thinks about competing with some of the well-known brands in the industry like Plant People and Steve’s Goods.
You can’t produce enough CBD-rich hemp to meet demand, which makes it a premium cannabinoid product. CBG converts into CBD and THC as cannabis grows.
If cultivators can overcome the obstacles of cultivating and extracting CBG, it may help drive down production costs.
The medical benefits of CBG are impressive. Non-psychoactive cannabinoid research is still in its infancy, but we see promising results.
This study, published in November 2019, asks the question: do CBD and CBG counteract neuroinflammation?
Their preliminary results support that this cannabinoid combination has potential therapeutic properties.
The unique compounds of cannabis are being backed by scientific research that proves how therapeutic they genuinely are.
CBG may be a minor cannabinoid when it comes to quantity, but this breakthrough is massive when it comes to benefits.
While there are hurdles to overcome, like hemp mass/ CBG level ratio, production cost, and lack of regulation, you can expect to see more CBG products appear on the market.
Cannabigerol (CBG) is present in many cannabis strains at low levels. We may be at the beginning of cannabinoid research. Here’s what we know about CBG so far.
This study is one of the few that look at CBG and how it interacts with our endocannabinoid system (ECS) and cannabinoid receptors.
What is CBG?
CBG is a minor cannabinoid that plays a critical role in cannabis cultivation. CBGA turns into THCA and CBDA, which, once activated (decarboxylated), converts to well-known cannabinoids THC and CBD.Enzymes in the cannabis plant break CBGA down into these more prominent cannabinoids. That’s why most strains contain less than 1% CBG.
A few cannabis breeders are playing around with cross-breeding and genetics to produce higher CBG levels.
Potentially Therapeutic Benefits
Our endocannabinoid system monitors, protect and regulate vital body functions. It interacts with many essential systems like our immune, digestive, and neurological systems.Your body has a built-in security system to promote homeostasis (body balance). We have cannabinoid receptors that act as messengers between our ECS and the rest of our body.
Cannabinoids from cannabis like CBG work with our ECS.
There are many reasons cannabinoids are beneficial. CBG is showing to be a vasodilator that has neuroprotective benefits. Meaning, cannabinoid therapies may be a valuable therapeutic treatment for symptoms associated with glaucoma.
Most studies are not human clinical trials. In an animal study, CBD effectively decreases inflammation related to IBS symptoms.
Like CBD and other non-psychoactive cannabinoids, CBG possesses antibacterial, antifungal, anti-inflammatory, and antitumor properties.
This study shows that CBG stays in the blood and can be a holistic treatment for unwanted symptoms brought on by stress.
Making CBG: Costly Cannabinoid
Cannabinoids are only going to become more prevalent, and the industry will only grow. Companies that take the initiative and create innovative products will likely succeed.The beginning of most of the cannabinoid’s journey starts with CBG. It could quite literally be the mother of cannabinoids.
This cannabinoid has an insane amount of potential. The therapeutic possibilities pique the interest of both consumers and researchers.
Some companies entering the cannabis scene focus specifically on CBD products. Minor cannabinoid research is gaining traction.
From alleviating physical pain to reducing stress and sadness, cannabinoids like CBG help your body heal itself- a scientific breakthrough.
The Future of CBG
Most people are still wrapping their heads around THC, CBD, edibles and other cannabis-related phrases. The innovators of the industry are so much farther ahead.You won’t see CBG on the market in masses any time soon.
There are so many hurdles a CBG cultivator has to overcome before he even thinks about competing with some of the well-known brands in the industry like Plant People and Steve’s Goods.
You can’t produce enough CBD-rich hemp to meet demand, which makes it a premium cannabinoid product. CBG converts into CBD and THC as cannabis grows.
If cultivators can overcome the obstacles of cultivating and extracting CBG, it may help drive down production costs.
The medical benefits of CBG are impressive. Non-psychoactive cannabinoid research is still in its infancy, but we see promising results.
This study, published in November 2019, asks the question: do CBD and CBG counteract neuroinflammation?
Their preliminary results support that this cannabinoid combination has potential therapeutic properties.
Wrapping it Up
Cannabis is a holistic recreational and medicinal tool that has been around for many generations.The unique compounds of cannabis are being backed by scientific research that proves how therapeutic they genuinely are.
CBG may be a minor cannabinoid when it comes to quantity, but this breakthrough is massive when it comes to benefits.
While there are hurdles to overcome, like hemp mass/ CBG level ratio, production cost, and lack of regulation, you can expect to see more CBG products appear on the market.
